Biotech

All Articles

Former Seagen chief executive officer reveals new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2014 for a whopping $43 bil...

Ironwood makes additional purpose $1B GI drug along with brand-new subgroup information

.On the heels of a period 3 succeed that failed to wow clients, Ironwood Pharmaceuticals is actually...

Novartis inks $150M package for autoimmune molecular glue

.Don't stop Monte Rosa Therapies currently. The Boston-based biotech is actually enjoying after sign...

Jade takes exec team with Chinook veterinarians-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Septerna goes public along with upsized offering of $288M

.Commemorating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer call...

AbbVie creates Richter richer, spending $25M to make up breakthrough treaty

.AbbVie has actually returned to the resource of its antipsychotic powerhouse Vraylar in search of y...

GenSight enters into ultimate weeks of money path as earnings stream squeezes by of reach

.GenSight Biologics is weeks out of running out of funds. Once again. The biotech only has adequate ...

AZ licenses thrown out rare ailment medicine to Monopar Therapies

.Monopar Therapeutics is recuperating a medicine coming from the dump of AstraZeneca's uncommon ailm...

Arcus' new HIF-2a data in kidney cancer mean potential upper hand over Merck's Welireg, professionals mention

.With new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of professionals wor...

Roche bets approximately $1B to increase Dyno gene therapy shipment treaty

.After developing a gene treatment alliance with Dyno Rehabs in 2020, Roche is actually back for eve...